Cargando…

Molecular Cytogenetic Analysis of 17 Renal Cancer Cell Lines: Increased Copy Number at 5q31‐33 in Cell Lines from Nonpapillary Carcinomas

Comparative genomic hybridization (CGH) was used to screen for genomic imbalances in cell lines derived from 13 nonpapillary renal‐cell carcinomas (RCCs), two papillary RCCs, one renal squamous‐cell carcinoma, and one transitional‐cell carcinoma of the renal pelvis. Aberrations were found in all 17...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zeng‐Quan, Yoshida, Mitsuaki A., Fukuda, Yoji, Kurihara, Naoki, Nakamura, Yusuke, Inazawa, Johji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926323/
https://www.ncbi.nlm.nih.gov/pubmed/10761702
http://dx.doi.org/10.1111/j.1349-7006.2000.tb00927.x
_version_ 1783318879500500992
author Yang, Zeng‐Quan
Yoshida, Mitsuaki A.
Fukuda, Yoji
Kurihara, Naoki
Nakamura, Yusuke
Inazawa, Johji
author_facet Yang, Zeng‐Quan
Yoshida, Mitsuaki A.
Fukuda, Yoji
Kurihara, Naoki
Nakamura, Yusuke
Inazawa, Johji
author_sort Yang, Zeng‐Quan
collection PubMed
description Comparative genomic hybridization (CGH) was used to screen for genomic imbalances in cell lines derived from 13 nonpapillary renal‐cell carcinomas (RCCs), two papillary RCCs, one renal squamous‐cell carcinoma, and one transitional‐cell carcinoma of the renal pelvis. Aberrations were found in all 17 lines. The most frequent changes in nonpapillary RCC cell lines were gains of 5q (85%), 7q (69%), 8q (69%) and 1q (54%) and losses of 3p (92%), 8p (77%), 4q (62%) and 14q (54%). High‐level gains (HLGs) were detected at 4q12, 5p, 5q23‐33, 7q22‐qter, 8q23‐24, 10q21‐qter, 12p and 12q13‐22. By means of fluorescence in situ hybridization (FISH) we narrowed the smallest common region involving 5q gains to the genomic segment between D5S642 and D5S673, and found that the HLG at 4q12 possibly involved amplifications of c‐kit and PDGFRA. Two papillary RCC cell lines showed gains of entire chromosomes 7, 12 and 17. The CGH data reported here should help to facilitate the choice of individual renal‐tumor cell lines for exploring target genes in regions of interest.
format Online
Article
Text
id pubmed-5926323
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-59263232018-05-11 Molecular Cytogenetic Analysis of 17 Renal Cancer Cell Lines: Increased Copy Number at 5q31‐33 in Cell Lines from Nonpapillary Carcinomas Yang, Zeng‐Quan Yoshida, Mitsuaki A. Fukuda, Yoji Kurihara, Naoki Nakamura, Yusuke Inazawa, Johji Jpn J Cancer Res Article Comparative genomic hybridization (CGH) was used to screen for genomic imbalances in cell lines derived from 13 nonpapillary renal‐cell carcinomas (RCCs), two papillary RCCs, one renal squamous‐cell carcinoma, and one transitional‐cell carcinoma of the renal pelvis. Aberrations were found in all 17 lines. The most frequent changes in nonpapillary RCC cell lines were gains of 5q (85%), 7q (69%), 8q (69%) and 1q (54%) and losses of 3p (92%), 8p (77%), 4q (62%) and 14q (54%). High‐level gains (HLGs) were detected at 4q12, 5p, 5q23‐33, 7q22‐qter, 8q23‐24, 10q21‐qter, 12p and 12q13‐22. By means of fluorescence in situ hybridization (FISH) we narrowed the smallest common region involving 5q gains to the genomic segment between D5S642 and D5S673, and found that the HLG at 4q12 possibly involved amplifications of c‐kit and PDGFRA. Two papillary RCC cell lines showed gains of entire chromosomes 7, 12 and 17. The CGH data reported here should help to facilitate the choice of individual renal‐tumor cell lines for exploring target genes in regions of interest. Blackwell Publishing Ltd 2000-02 /pmc/articles/PMC5926323/ /pubmed/10761702 http://dx.doi.org/10.1111/j.1349-7006.2000.tb00927.x Text en
spellingShingle Article
Yang, Zeng‐Quan
Yoshida, Mitsuaki A.
Fukuda, Yoji
Kurihara, Naoki
Nakamura, Yusuke
Inazawa, Johji
Molecular Cytogenetic Analysis of 17 Renal Cancer Cell Lines: Increased Copy Number at 5q31‐33 in Cell Lines from Nonpapillary Carcinomas
title Molecular Cytogenetic Analysis of 17 Renal Cancer Cell Lines: Increased Copy Number at 5q31‐33 in Cell Lines from Nonpapillary Carcinomas
title_full Molecular Cytogenetic Analysis of 17 Renal Cancer Cell Lines: Increased Copy Number at 5q31‐33 in Cell Lines from Nonpapillary Carcinomas
title_fullStr Molecular Cytogenetic Analysis of 17 Renal Cancer Cell Lines: Increased Copy Number at 5q31‐33 in Cell Lines from Nonpapillary Carcinomas
title_full_unstemmed Molecular Cytogenetic Analysis of 17 Renal Cancer Cell Lines: Increased Copy Number at 5q31‐33 in Cell Lines from Nonpapillary Carcinomas
title_short Molecular Cytogenetic Analysis of 17 Renal Cancer Cell Lines: Increased Copy Number at 5q31‐33 in Cell Lines from Nonpapillary Carcinomas
title_sort molecular cytogenetic analysis of 17 renal cancer cell lines: increased copy number at 5q31‐33 in cell lines from nonpapillary carcinomas
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926323/
https://www.ncbi.nlm.nih.gov/pubmed/10761702
http://dx.doi.org/10.1111/j.1349-7006.2000.tb00927.x
work_keys_str_mv AT yangzengquan molecularcytogeneticanalysisof17renalcancercelllinesincreasedcopynumberat5q3133incelllinesfromnonpapillarycarcinomas
AT yoshidamitsuakia molecularcytogeneticanalysisof17renalcancercelllinesincreasedcopynumberat5q3133incelllinesfromnonpapillarycarcinomas
AT fukudayoji molecularcytogeneticanalysisof17renalcancercelllinesincreasedcopynumberat5q3133incelllinesfromnonpapillarycarcinomas
AT kuriharanaoki molecularcytogeneticanalysisof17renalcancercelllinesincreasedcopynumberat5q3133incelllinesfromnonpapillarycarcinomas
AT nakamurayusuke molecularcytogeneticanalysisof17renalcancercelllinesincreasedcopynumberat5q3133incelllinesfromnonpapillarycarcinomas
AT inazawajohji molecularcytogeneticanalysisof17renalcancercelllinesincreasedcopynumberat5q3133incelllinesfromnonpapillarycarcinomas